|
Index of reports
> Cases with Impaired Work Ability ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include impaired work ability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible PEG-Intron side effects in 61 year old male
Reported by a physician from United States on 2012-06-13
Patient: 61 year old male
Reactions: Gastrointestinal Motility Disorder, Pain, Impaired Work Ability, Emotional Disorder, Haemoglobin Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: bid
Indication: Hepatitis C
Start date: 2012-05-01
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2012-05-01
Other drugs received by patient: Vitamins E; Vitamins C
Possible PEG-Intron side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: male
Reactions: Confusional State, Fatigue, Impaired Work Ability, Depression, Suicidal Ideation
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
PEG-Intron
Indication: Hepatitis C
Victrelis
Indication: Hepatitis C
Other drugs received by patient: Zoloft
Possible PEG-Intron side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: 62 year old male
Reactions: Rash Generalised, Fatigue, Impaired Work Ability, Mouth Ulceration, Decreased Appetite
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg; tid;
Indication: Hepatitis C
Start date: 2011-11-18
Ribasphere
Indication: Hepatitis C
PEG-Intron
Dosage: 800 mg;tid
Indication: Hepatitis C
Possible PEG-Intron side effects in 45 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02
Patient: 45 year old male
Reactions: Fatigue, Vomiting, Nausea, Sensory Disturbance, Feeling Hot, Impaired Work Ability, Asthenia, Feeling Cold
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg; tid; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-11
End date: 2012-01-22
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-26
Patient: female
Reactions: Blood Pressure Increased, Vomiting, Nausea, Impaired Work Ability, Dehydration, Asthenia, Blood Glucose Increased, Decreased Appetite
Drug(s) suspected as cause:
Ribavirin
Dosage: ;unk;unk
Indication: Hepatitis C
Start date: 2012-01-06
PEG-Intron
Dosage: ;unk;unk
Indication: Hepatitis C
Start date: 2012-01-06
Possible PEG-Intron side effects in 44 year old female
Reported by a consumer/non-health professional from United States on 2011-12-20
Patient: 44 year old female
Reactions: Impaired Work Ability, Gait Disturbance, Amnesia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Rebetol
Indication: Hepatitis C
Possible PEG-Intron side effects in 53 year old male
Reported by a consumer/non-health professional from Canada on 2011-10-20
Patient: 53 year old male
Reactions: Anxiety, Weight Decreased, Malaise, Impaired Work Ability, Alopecia, Headache, Mood Swings
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-03
Patient: male
Reactions: Haemoglobin Decreased, Haematochezia, Pneumonia, Thinking Abnormal, RED Blood Cell Count Decreased, Impaired Work Ability, Aphasia, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-06-24
Ribavirin
Dosage: 600 mg;bid, bid;unk
Indication: Hepatitis C
Start date: 2011-06-24
Telaprivir
Dosage: unk;unk
Indication: Hepatitis C
Start date: 2011-06-24
End date: 2011-09-16
|
